Cargando…
Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
BACKGROUND: The procoagulant state in cancer increases the thrombotic risk, but also supports tumor progression. To investigate the molecular mechanisms controlling cancer and hemostasis, we conducted a case-control study of genotypic and phenotypic variables of the tissue factor (TF) pathway of coa...
Autores principales: | Tinholt, Mari, Viken, Marte Kathrine, Dahm, Anders Erik, Vollan, Hans Kristian Moen, Sahlberg, Kristine Kleivi, Garred, Øystein, Børresen-Dale, Anne-Lise, Jacobsen, Anne Flem, Kristensen, Vessela, Bukholm, Ida, Kåresen, Rolf, Schlichting, Ellen, Skretting, Grethe, Lie, Benedicte Alexandra, Sandset, Per Morten, Iversen, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251949/ https://www.ncbi.nlm.nih.gov/pubmed/25407022 http://dx.doi.org/10.1186/1471-2407-14-845 |
Ejemplares similares
-
Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
por: Tinholt, Mari, et al.
Publicado: (2015) -
Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer
por: Tinholt, Mari, et al.
Publicado: (2020) -
Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer
por: Aure, Miriam Ragle, et al.
Publicado: (2015) -
TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity
por: Stavik, Benedicte, et al.
Publicado: (2013) -
Indirect regulation of TFPI-2 expression by miR-494 in breast cancer cells
por: Andresen, Marianne S., et al.
Publicado: (2020)